(Q36451110)

14 August 2017

0 references

p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis (English)

1 reference

14 August 2017

Feng Wei

1

1 reference

14 August 2017

Jin Xu

2

1 reference

14 August 2017

Lin Tang

3

1 reference

14 August 2017

Jiaqing Shao

4

1 reference

14 August 2017

Yucai Wang

5

1 reference

14 August 2017

Longbang Chen

6

1 reference

14 August 2017

Xiaoxiang Guan

7

1 reference

14 August 2017

23 July 2012

1 reference

Cancer Biotherapy and Radiopharmaceuticals

14 August 2017

1 reference

14 August 2017

27

1 reference

14 August 2017

10

1 reference

14 August 2017

665-671

1 reference

Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Hallmarks of Cancer: The Next Generation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

SNP-SNP interactions in breast cancer susceptibility

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Discovery and evaluation of dual CDK1 and CDK2 inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Bias in meta-analysis detected by a simple, graphical test

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

A comparison of methods to detect publication bias in meta-analysis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

The sweet secrets of p27kip1 regulation and function in cell migration.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

An alternative measure of effect size for Cochran's Q test for related proportions

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

[Practical considerations on detection of publication bias].

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516414

CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan

21 September 2018

1 reference

12 December 2020

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma

1 reference

12 December 2020

Analysis of data from multiclinic trials

1 reference

12 December 2020

Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women

1 reference

12 December 2020

P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1089/CBR.2012.1229

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22823061

1 reference